Iterum TherapeuticsITRMF
13F holders, Q2 2025 (June 30)21holders +3
5new positions
2sold out
1famous investor
$0.99avg. 13F price*
At the end of Q2 2025, 21 institutions reported holding Iterum Therapeutics PLC (ITRMF) in their 13F filings, up 3 from Q1 2025. 5 opened new positions and 2 sold out. The largest holders were Renaissance Technologies ($470K), Squarepoint Ops LLC ($455K) and Sabby Management, LLC ($429K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Iterum Therapeutics PLC
- CUSIP
- G6333L200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $980K |
| Exits | 2 | $33K |
All 13F filers, Q1 2025 → Q2 2025: 1,279,083 shares bought and 26,711 shares sold, net +1,252,372 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Renaissance Technologies | 0.00% | Add +95.9% | 471,900 | $470K |
| Squarepoint Ops LLC | 0.00% | New | 456,861 | $455K |
| Sabby Management, LLC | 3.47% | New | 430,761 | $429K |
| New Leaf Venture Partners, L.L.C. | 0.65% | No change | 345,020 | $343K |
| Apollon Financial, LLC | 0.05% | No change | 250,250 | $249K |
| OneDigital Investment Advisors LLC | 0.00% | Add +59.4% | 161,000 | $160K |
| Jane Street Group, LLC | 0.00% | New | 92,943 | $92K |
| Two Sigma Investments, LP | 0.00% | No change | 25,245 | $25K |
| Sanctuary Advisors, LLC | 0.00% | No change | 20,000 | $20K |
| Geode Capital Management, LLC | 0.00% | No change | 12,370 | $12K |
| Alpine Global Management, LLC | 0.00% | No change | 10,000 | $10K |
| Morgan Stanley | 0.00% | Add +44.8% | 9,373 | $9K |
| UBS Group AG | 0.00% | Add +1.1% | 8,799 | $9K |
| Raymond James Financial Inc. | 0.00% | New | 4,513 | $4K |
| Medallion Wealth Advisors, LLC | 0.00% | No change | 1,680 | $2K |
| Activest Wealth Management | 0.00% | No change | 133 | $132 |
| Wells Fargo & Company | 0.00% | No change | 85 | $85 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -11.1% | 16 | $16 |
| NFSG Corp | 0.00% | No change | 15 | $15 |
| HM Payson & Co. | 0.00% | No change | 3 | $3 |
| Royal Bank of Canada | 0.00% | New | 5 | $0 |
"% of holder's portfolio" is ITRMF's weight in each manager's 13F, not the share of Iterum Therapeutics PLC the manager owns.